Article Versions Notes

Zhu J, Jiao D, Wang C, Lu Z, Chen X, Li L, Sun X, Qin L, Guo X, Zhang C, et al. Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen. Cancers. 2022; 14(18):4508. https://doi.org/10.3390/cancers14184508

Zhu, Jiujun, Dechuang Jiao, Chengzheng Wang, Zhenduo Lu, Xiuchun Chen, Lianfang Li, Xianfu Sun, Li Qin, Xuhui Guo, Chongjian Zhang, and et al. 2022. "Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen" Cancers 14, no. 18: 4508. https://doi.org/10.3390/cancers14184508

Zhu, J., Jiao, D., Wang, C., Lu, Z., Chen, X., Li, L., Sun, X., Qin, L., Guo, X., Zhang, C., Qiao, J., Yan, M., Cui, S., & Liu, Z. (2022). Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen. Cancers, 14(18), 4508. https://doi.org/10.3390/cancers14184508